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INTRODUCTION
Histamine released from mast cells and basophils plays an 
important role in the pathophysiology of allergic diseases, such 
as asthma, allergic rhinitis, urticaria, and anaphylaxis.
1,2 Hista-
mine exerts various effects through four histamine receptors. 
Allergic symptoms, such as itching, pain, vasodilation, hypo-
tension, flushing, bronchoconstriction, and the stimulation of 
cough receptors, develop mainly through histamine receptor 1 
(H1R), making this receptor a major target of allergic medica-
tions.
1,2 H1R histamine antagonists can be further classified as 
first- or second-generation agents; whereas a first-generation 
drug may have a sedative effect, due to an interaction with re-
ceptors in the central nervous system, second-generation agents 
are less lipophilic and are thus less able to cross the blood-brain 
barrier to induce a sedative effect.
1,2 Interestingly, however, an-
tihistamine treatment itself may also elicit an allergic response. 
Several cases of hypersensitivity reactions against piperazine 
derivatives such as cetirizine, hydroxyzine, levocetirizine, and 
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loratadine have been reported.
3-6 However, hypersensitivity re-
actions to alkylamine derivatives such as chlorpheniramine 
maleate are extremely rare, particularly a type I reaction.
7,8 To 
date, only one case of chlorpheniramine-induced type I hyper-
sensitivity with aspirin intolerance has been reported. Here, we 
report a second case of type I hypersensitivity to chlorphenira-
mine maleate with aspirin intolerance.
Case Report
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Antihistamines are commonly used to treat allergic disease, such as allergic rhinitis, urticaria, and angioedema. Although several previous reports 
describe hypersensitivity to antihistamines such as cetirizine and hydroxyzine, documented cases of chlorpheniramine hypersensitivity are extremely 
rare. Here, we report the case of a 45-year-old Korean woman who presented with urticaria after ingesting a cold medication. Over the previous 5 
years, she had also experienced a food allergy to crab and shrimp, allergic rhinitis, and repeated urticaria after ingesting cold medication. Provoca-
tion with aspirin elicited generalized urticaria. Intravenous chlorpheniramine and methylprednisolone was injected for symptom control, but in fact 
appeared to aggravate urticaria. A second round of skin and provocation tests for chlorpheniramine and methylprednisolone showed positive results 
only for chlorpheniramine. She was diagnosed with aspirin intolerance and chlorpheniramine hypersensitivity, and was instructed to avoid these 
drugs. To date, this is the second of only two cases of chlorpheniramine-induced type I hypersensitivity with aspirin intolerance. Although the rela-
tionship between aspirin intolerance and chlorpheniramine-induced type I hypersensitivity is unclear, physicians should be aware of the possibility 
of urticaria or other allergic reactions in response to antihistamines.
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CASE REPORT
A 45-year-old woman visited the Asthma and Allergy Clinic of 
Seoul National University at Bundang Hospital seeking treat-
ment for urticaria after taking cold medicine. She reported a 
5-year history of urticaria, rash, and most recently mild dys-
pnea after taking cold medications. The patient indicated that 
she had never taken aspirin before and could not recall wheth-
er she had ever experienced an adverse reaction to acetamino-
phen. She also suffered from allergic rhinitis and a food allergy 
to crab and shrimp. Her mother had a history of penicillin aller-
gy, but no other allergic disease. At the time of presentation, the 
patient had recently consumed medications containing clar-
ithromycin, loxoprofen, acetaminophen, cimetidine, metoclo-
pramide, magnesium oxide, chlorpheniramine, and simethi-
cone. Physical examination showed no specific signs. Blood 
analyses indicated her leukocyte count to be 22,890×10
3 cells/
μL (neutrophils, 58.6%; lymphocytes, 22.4%; monocytes, 4.9%; 
eosinophils, 0.3%) and other blood cell counts were within nor-
mal ranges. The patient’s total IgE level was elevated at 333 IU/
mL.
A skin prick test for inhalant allergens (Allergopharma, Rein-
bek, Germany) showed strong positive responses for Derma-
tophagoides farinae, Dermatophagoides pteronyssinus, Tyroph-
agus putrescentiae, and Tetranychus urticae. A methacholine 
bronchial provocation test elicited no abnormal response. As 
we suspected aspirin idiosyncrasy, an oral provocation test was 
performed by administering an oral placebo drug, followed by 
sequential aspirin administration (25, 50, and 100 mg) at 30-
min intervals. Within 30 min of the 100-mg oral dose, urticaria 
developed at the lips and on both arms and hands, with accom-
panying eyelid edema. The patient did not complain of dyspnea 
and her forced expiratory volume in one second (FEV1) did not 
decrease. We concluded that the provocation test was positive 
and diagnosed her with aspirin idiosyncrasy. For symptomatic 
control, we administered intravenous chlorpheniramine at 45.5 
mg and methylprednisolone at 40 mg. However, this treatment 
aggravated urticaria and we subsequently performed another 
round of skin prick and intradermal tests for chlorpheniramine, 
methylprednisolone, hydrocortisone, dexamethasone, and tri-
amcinolone. Positive skin prick (3×3 mm) and intradermal 
(wheal, 7×6 mm; flare, 10×10 mm) responses were observed for 
chlorpheniramine (Figure), but not methylprednisolone, lead-
ing to suspicion of chlorpheniramine hypersensitivity. To obtain 
a definitive diagnosis, we performed an intramuscular chlor-
pheniramine provocation test. Briefly, three solutions (0.25 mL 
normal saline, 0.25 mL chlorpheniramine at 22.75 mg/mL, and 
2 mL chlorpheniramine at 22.75 mg/mL) were prepared and 
then labeled in such a manner so as to blind the administering 
physician (treatments A, B, and C, respectively). We adminis-
tered each drug intramuscularly and observed the patient’s re-
sponse every 30 min. No response was observed after the injec-
tion of solution A (control); however, the injection of solution B 
elicited tiny reddish papules on the patient’s neck and both arms, 
and these lesions worsened after injecting solution C. We thus 
diagnosed the patient with chlorpheniramine hypersensitivity. 
The patient tolerated fexofenadine before. Skin prick, intrader-
mal, and oral provocation tests for antibiotics such as penicillin 
and cephalosporins showed no positive result. Provocation tests 
with acetaminophen and celecoxib were negative. Finally, we 
diagnosed the patient with aspirin idiosyncrasy and chlorphe-
niramine hypersensitivity, and recommended her to avoid these 
two drugs. Subsequently, for the past 3 years, she has not expe-
rienced recurrence of the reported symptoms.
 
DISCUSSION
Antihistamine hypersensitivity is very unusual, with only a few 
published reports of hypersensitivity reactions to piperazine de-
rivatives, such as cetirizine, hydroxyzine, and loratadine.
3-6 In 
contrast, hypersensitivity to alkylamine derivatives such as chlor-
pheniramine is extremely rare,
7,8 particularly a type I reac-
tion.
9 Recently, in Korea, the case of a 42-year-old male display-
ing urticaria, angioedema, dyspnea, and hypotension after in-
gesting chlorpheniramine and cetylpyridium was reported; this 
patient also suffered from aspirin-intolerant asthma.
10 The au-
thors confirmed chlorpheniramine hypersensitivity through 
both skin tests and oral provocation. Although the ingestion of 
0.5 mg chlorpheniramine resulted in urticaria, cetylpyridium 
provocation elicited no response. The patient tolerated oral 
provocation with cetirizine, although a skin prick test with the 
same compound elicited a positive response. This case is nota-
ble compared to our case because both are characterized by as-
pirin intolerance. Aspirin has been known to aggravate food-
dependent exercise-induced anaphylaxis.
11 However, the rela-
tionship between aspirin intolerance and chlorpheniramine hy-
persensitivity is unclear. This is the second case report of chlor-
Figure.  Intradermal test showed positive response only to chlorpheniramine 
(M, methylprednisolone; C, hydrocortisone; D, dexamethasone; T, triamcino-
lone; N, normal saline; Ph, chlorpheniramime; H, histamine; ×1/10, 1:10 dilu-
tion; ×1/100, 1:100 dilution). Kim et al.
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pheniramine hypersensitivity with aspirin intolerance.
Allergic responses to chlorpheniramine in skin prick, intra-
dermal, and oral provocation tests points to IgE-mediated type 
I hypersensitivity as the mechanism of chlorpheniramine hy-
persensitivity reaction in this case. In a previous study, a hyper-
sensitive patient showing a positive patch test to cetirizine also 
reacted positively to patch tests for hydroxyzine and levocetiri-
zine, suggesting cross-reactivity between antihistamines in the 
same chemical family.
4 In one of our own previous studies, 
cross-reactivity between antihistamines was confirmed using 
the oral provocation test in a patient with cetirizine hypersensi-
tivity. We observed cross-reactivity between cetirizine and hy-
droxyzine (piperazine family), but not with levocetirizine (pi-
perazine), loratadine (piperidine), fexofenadine (piperidine), 
ebastine (piperidine), or chlorpheniramine (alkylamine). These 
results indicated that piperidine or alkylamine antihistamines 
may be safe alternative drugs in the case of piperazine hypersen-
sitivity.
12 However, for a patient with hypersensitivity to chlorphe-
niramine, a member of the alkylamine derivatives, it would be 
better to avoid similar alkylamine derivatives such as dexchlor-
pheniramine, bromchlorpheniramine, and triprolidine, or to 
use the piperazine, piperidine, or ethanolamine derivatives 
with caution. Further study is needed to better understand 
cross-reactivity within antihistamines.
Here, we described a case of chlorpheniramine-induced type 
I hypersensitivity with aspirin-induced urticaria. Physicians 
should be aware of the possibility of urticaria or other allergic 
responses in response to antihistamines.
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